Filter
6043
Filtered Results: 6043
Text search:
drugs
act
Featured
Recommendations
508
New Publications
1614
Language
Document type
No document type
3804
Studies & Reports
781
Guidelines
755
Manuals
243
Strategic & Response Plan
169
Fact sheets
104
Training Material
101
Situation Updates
30
Infographics
22
Brochures
17
Resource Platforms
13
Online Courses
3
Videos
1
Countries / Regions
India
397
Kenya
198
Global
152
South Africa
150
Ethiopia
132
Nigeria
131
Uganda
126
Nepal
123
Sierra Leone
120
Western and Central Europe
110
Zambia
104
Tanzania
96
Liberia
94
Malawi
94
Ghana
88
Rwanda
87
Bangladesh
81
Latin America and the Carribbean
77
Africa
75
Myanmar / Burma
68
Ukraine
64
Eastern Europe
57
Philippines
55
Namibia
49
Zimbabwe
47
Asia
46
Indonesia
42
South–East Asia Region
39
Russia
39
Congo, Democratic Republic of
38
Lesotho
38
Burkina Faso
36
Senegal
36
Cambodia
36
Syria
34
Mozambique
34
Botswana
33
South Sudan
29
Eswatini/ Swaziland
24
East and Southern Africa
22
West and Central Africa
22
Germany
21
Colombia
21
Venezuela
21
Cameroon
19
Haiti
19
Brazil
19
Benin
18
Tajikistan
17
Guinea
14
Middle East and North Africa
14
Eastern Europe and Central Asia
14
Argentina
13
Paraguay
13
Afghanistan
12
Chile
12
Pakistan
11
Albania
11
Georgia
11
USA
10
Lebanon
10
Central African Republic
10
Sudan
9
Peru
9
Bolivia
9
Yemen
9
Vietnam
9
Thailand
8
China
8
Madagascar
8
Laos
8
Mali
7
North Macedonia
7
Moldova
7
Somalia
6
Ecuador
6
Sri Lanka
6
Armenia
6
Southern Africa
6
North America
6
Jordan
5
Mexico
5
Western Pacific Region
5
Bhutan
5
Palestine
5
Niger
4
Iraq
4
Burundi
4
Libya
4
Angola
4
Fiji
4
Kyrgyzstan
4
Jamaica
4
Guinea-Bissau
3
Côte d’Ivoire / Ivory Coast
3
Saudi Arabia
3
Egypt
3
Serbia
3
Greece
3
Iran
3
Uzbekistan
3
Morocco
2
Turkey
2
Chad
2
Gambia
2
Singapore
2
Papua New Guinea
2
Hungary
2
El Salvador
2
Poland
2
Mongolia
2
Canada
2
Timor Leste/ East Timor
2
Qatar
2
Estonia
2
Romania
2
Lithuania
2
Kazakhstan
2
Uruguay
2
Turkmenistan
2
United Kingdom
2
Ireland
1
Switzerland
1
Honduras
1
Guatemala
1
Nicaragua
1
Solomon Islands
1
North Korea
1
Djibouti
1
Congo-Brazzaville
1
Bulgaria
1
Australia
1
Gabon
1
Japan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Portugal
1
Spain
1
Azerbaijan
1
Belarus
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
2484
Clinical Guidelines
530
Public Health
268
Women & Child Health
257
Key Resources
123
Capacity Building
109
Pharmacy & Technologies
61
Annual Report MEDBOX
1
Toolboxes
HIV
742
Mental Health
580
TB
479
COVID-19
268
AMR
243
Pharmacy
220
NTDs
142
Caregiver
140
NCDs
123
Ebola
95
Refugee
92
Conflict
91
Rapid Response
91
Disability
79
Planetary Health
76
Global Health Education
58
Health Financing Toolbox
40
Natural Hazards
39
Zika
21
Polio
19
Cholera
18
Specific Hazards
17
Social Ethics
12
South Sudan
2
Health Financing
1
No vaccines or drugs to prevent infection are available. The best way for travelers to prevent infection is to protect themselves from sand fly bites. To decrease the risk of being bitten, follow these preventive measures:
Avoid outdoor ...ivities, especially from dusk to dawn, when sand flies generally are the most active.
Many vaccines and drugs hold the promise of reducing mortality and morbidity among pregnant women and infants living in low- and middle-income countries (LMICs). However, sufficient information on the safety of ... and vaccines in pregnant women is rarely available at the time of product licensure or approval. To account for this, active safety surveillance efforts are needed during the post-licensure and post-approval
phase to assess the safety of drugs and vaccines in pregnant women and their offspring. Pregnancy exposure registries (PER) are used to monitor the safety of vaccines and drugs. PERs are observational studies that systematically collect health information on exposure to medical products such as drugs and vaccines during pregnancy. This review demonstrates that a number of resources presently exist in LMICs that perform active safety surveillance in pregnant populations. These results indicate such systems employ a wide variety of approaches, each with their own set of strengths and challenges, as summarized in the final section of the report.
The Ministry of Health, through the Zimbabwe Essential Drugs Action Programme, has produced this module for use by primary health care workers in Zimbabwe. The module aims to provide the minimum nec...
The pamphlet "Prescription Benzodiazepines" explains the uses, effects, and risks of benzodiazepines, commonly prescribed for insomnia, anxiety, and panic attacks. It describes how these drugs enhance GABA ...ivity to suppress brain activity, leading to short-term effects like drowsiness and anxiety relief, but also potential long-term risks such as dependence, addiction, and withdrawal symptoms. The pamphlet highlights abuse methods, including combining benzodiazepines with other substances, which increases the risk of overdose, and emphasizes the importance of medical supervision for withdrawal management.
Antibiotics, also known as antimicrobial drugs, are medicines that can kill or inhibit the growth of bacteria to cure infections in people, animals and sometimes plants. Antibiotics are medicines for bacterial infections (such as pneumococcal pneumo...
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i...
FDA’s compounding program aims to protect patients from unsafe, ineffective and poor quality compounded drugs, while preserving access to lawfully-marketed compounded drugs for patients who have a...
Spread of resistance to antimicrobial agents (AMR) does not know national borders and has reached dimensions, which require immediate actions at the national, regional and global levels.
Antibiotic resistance is a natural biological response to imp...
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisini...
For 50 patients requiring surgical care in emergency situations assuming 2 operations per patient (100 interventions)
WHO trauma and emergency surgery kit (TESK) aims to provide materials and drugs to meet the needs of 50 patients requiring surgi...
Chagas disease affects approximately 6 million people, mainly in Latin America. Less than 1% of affected individuals receive proper antiparasitic treatment, and current drugs are inadequate to fight the entire spectrum of the disease. Against this b...
Human African Trypanosomiasis (HAT, sleeping sickness) and Animal African Trypanosomiasis (AAT) are neglected tropical diseases generally caused by the same etiological agent, Trypanosoma brucei. Despite important advances in the reduction or disappearance of HAT cases, AAT represents a risky reserv...
The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased risk for heart failure (HF). Moreover, HF patients wit...
Millennium Development Goal 8E aims for affordable access to essential medicines. Essential medicines, as defined by WHO, are those that “satisfy the health-care needs of the majority of the population” and that should therefore “be available at all times in adequate amounts”. However, there...
Demographic and epidemiological transitions are changing the age structure of the population and the most common diseases. Non-communicable respiratory diseases are an increasing problem at both ends of the age range in low-income and middle-income countries. In children, who represent a large propo...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
Tanzania, like other developing countries, is facing a higher burden of cardiovascular diseases (CVDs). The country is experiencing rapid growth of modifiable and intermediate risk factors that accelerate CVD mortality and morbidity rates. In rural and urban settings, cardiovascular risk factors suc...
A.55 Medicines and Related Substances Act, 2013 | No. 8 of 2013 | An Act to provide for the registration, regulation of the sale, distribution, importation, exportation, manufacture and dispensing o...
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide for the functions and powers of the Authority; provi...
GOVERNMENT NOTICE | No. 192 Promulgation of Medicines and Related Substances Control Act, 2003 (Act No. 13 of 2003), of the Parliament
